Avillion names Jarrod Longcor CBO
This article was originally published in Scrip
Executive Summary
The UK's Avillion, a co-developer of late-stage pharmaceutical assets, has named Jarrod Longcor chief business officer. Mr Longcor has over 18 years of pharmaceutical and biotech experience and was previously vice-president of corporate development for Rib-X Pharmaceuticals (now Melinta Therapeutics).